Search clinical trials for: GSK2849330

Total 4 results

GlaxoSmithKline

Completed

Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors

Neoplasms | Cancer

Netherlands
GlaxoSmithKline

Completed

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors

Neoplasms | Cancer

Australia, United States, Netherlands
GlaxoSmithKline

Completed

Safety Escalating Repeat IV, in Stroke Patients (MAG111539)

Ischaemic Attack, Transient

Germany, Canada, United States
GlaxoSmithKline

Terminated

Proof of Concept (POC) in Patients With Ischaemic Stroke

Cerebrovascular Accident

Germany, Canada, United Kingdom, United States

3

Subscribe